Table 2 Comparisons of clinical baseline features
Feature | Controls | CHF | P value |
|---|---|---|---|
(N = 78) | (N = 82) | ||
Age (year) | 65.44 ± 1.41 | 64.93 ± 1.44 | 0.887 |
Gender (male/female) | 41/37 | 45/37 | 0.770 |
BMI (kg/m2) | 24.96 ± 0.325 | 25.07 ± 0.345 | 0.988 |
Smoking history (never/ever) | 61/17 | 68/14 | 0.453 |
Drinking history (never/ever) | 54/24 | 57/25 | 0.969 |
TC (nM) | 4.65 ± 0.18 | 4.62 ± 0.17 | 0.282 |
TG (nM) | 1.34 ± 0.63 | 1.42 ± 0.66 | 0.439 |
LDL-C (nM) | 2.93 ± 0.15 | 3.05 ± 0.13 | 0.865 |
HDL-C (nM) | 1.17 ± 0.33 | 1.18 ± 0.05 | 0.781 |
UA (µM) | 355.23 ± 14.95 | 352.38 ± 13.51 | 0.207 |
BNP (ng/l) | 66.57 ± 20.93 | 1564.595 ± 875.43 |  < 0.001 |
LVEF (%) | 58.76 ± 0.64 | 29.93 ± 3.52 |  < 0.001 |
Complication (no/yes) | |||
Hypertension | 44/34 | 57/25 | 0.0870 |
Diabetes | 47/31 | 53/29 | 0.5704 |
COPD | – | 69/13 | – |
Anemia | – |  | – |
Fluid and electrolyte imbalance | – | 45/37 | – |
NYHA stage | |||
I | – | 15 | – |
II | – | 29 | – |
III | – | 27 | – |
IV | – | 11 | – |